Classified

BRIDG - Biomedical Research Integrated Domain Group Model

The Biomedical Research Integrated Domain Group (BRIDG) Model is a collaborative effort engaging stakeholders from the Clinical Data Interchange Standards Consortium (CDISC), the HL7 Regulated Clinical Research Information Management Technical Committee (RCRIM TC), the National Cancer Institute (NCI) and its Cancer Biomedical Informatics Grid (caBIGĀ®), and the US Food and Drug Administration (FDA). The BRIDG model is an instance of a Domain Analysis Model (DAM). The goal of the BRIDG Model is to produce a shared view of the dynamic and static semantics for the domain of protocol-driven research and its associated regulatory artifacts. This domain of interest is further defined as: Protocol-driven research and its associated regulatory artifacts: i.e. the data, organization, resources, rules, and processes involved in the formal assessment of the utility, impact, or other pharmacological, physiological, or psychological effects of a drug, procedure, process, or device on a human, animal, or other subject or substance plus all associated regulatory artifacts required for or derived from this effort, including data specifically associated with post-marketing adverse event reporting. This OWL version of the BRIDG model is create by the National Cancer Institute (NCI). Source repository: https://ncisvn.nci.nih.gov/WebSVN/listing.php?repname=bridg-model&path=%2Ftrunk%2FModel+-+OWL%2F&

Ontology metadata

Homepage http://www.bridgmodel.org/
Contactclynch@surewest.net
Topicsdata management, pharmacology, physiology, psychiatry, preclinical and clinical studies, pharmacovigilence
SpeciesAll life
Class Count326
Unsatisfiable classes0
dc:description
The Biomedical Research Integrated Domain Group (BRIDG) Model is a collaborative effort . The BRIDG model is an instance of a Domain Analysis Model (DAM). The goal of the BRIDG Model is to produce a shared view of the dynamic and static semantics for the domain of protocol-driven research and its associated regulatory artifacts. This domain of interest is further defined as:
    
    Protocol-driven research and its associated regulatory artifacts: i.e. the data, organization, resources, rules, and processes involved in the formal assessment of the utility, impact, or other pharmacological, physiological, or psychological effects of a drug, procedure, process, or device on a human, animal, or other subject or substance plus all associated regulatory artifacts required for or derived from this effort, including data specifically associated with post-marketing adverse event reporting.
dc:issued
2012-08-31
dc:language
en-US
rdfs:label
Biomedical Research Integrated Domain Group (BRIDG) Domain Analysis Model
Date Download
Wed, 29 Aug 2012 23:00:00 GMT Download...

Query
OWL ClassOntologyLabelDefinition

Query
TitleAbstract

Query
LabelDescriptionDatasetDatatype(s)

See examples...

Use OBO-style URIs:

SPARQL Endpoint URI:

Versions

Properties